Pharma Business International | The voice of the Pharma industry

Appointments

Great Place To Work and Fortune name Chiesi Group No. 23 in 2024 World’s Best Workplaces™ list

14th November 2024

Chiesi Group, an international biopharmaceutical company focused on research, has been named one of the 25 World’s Best Workplaces™ in 2024 by Great Place To Work® (GPTW) and Fortune...

Appointments

Pillsbury growth in London continues with arrival of Cross-border Disputes and International Arbitration Partner Laurence Lieberman

MANUFACTURING

Process filter maker creates new global pharma and healthcare role

View the Online Magazine

Merck opens new €290m biosafety testing facility

Merck has opened its new €290 million biosafety testing facility in Rockville, Maryland, USA. Biosafety testing and analytical development are fundamental components of drug...

Beckman Coulter and Scopio Labs add world’s first digital bone marrow imaging and analysis to long-term partnership

Beckman Coulter, a clinical diagnostics leader, and Scopio Labs, a medtech company that develops digital cell morphology workflow solutions, jointly announced the expansion of...

DOL Finder platform launch enables users to identify and monitor most influential digital healthcare professionals active in key disease spaces

A UK and US based digital insights consultancy has launched a new platform, DOL Finder, that enables users to identify the most influential healthcare...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

Camida wins Pharma Supplier of the Year!

The much-coveted title, Pharma Supplier of the Year, was bestowed upon Camida at the 2024 Pharma Industry Awards. (Wednesday, 30 October / Dublin, Ireland) Camida...

AscellaHealth acquires CHAPPER healthcare

AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, has acquired CHAPPER healthcare, a global specialty pharmaceutical wholesaler, distributor and...

ProductLife Group strengthens global drug development capabilities with acquisition of IntiQuan

ProductLife Group (PLG), a regulatory, scientific, compliance, and digital transformation consulting services firm for the life sciences industry, has acquired IntiQuan, a Swiss boutique...

Astoriom expands biorepository services with new acquisition

Astoriom, a leader in the R&D Sample Stability and Biorepository Storage industry, has acquired the biorepository business of Flagship Biosciences as it strategically expands within the...

Approvals

Fasenra approved in the EU for eosinophilic granulomatosis with polyangiitis

AstraZeneca’s Fasenra (benralizumab) has been approved in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis...

Health Canada approves oral targeted treatment for brain cancer

Servier Canada has secured approval for VORANIGO (vorasidenib tablets), the first targeted therapy for the treatment of Grade 2 isocitrate dehydrogenase (IDH)-mutant glioma in...

Astellas’ VYLOYTM approved by U.S. FDA for advanced gastric and GEJ cancer

DARZALEX (daratumumab)-SC based quadruplet regimen approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible

U.S. FDA approves AbbVie’s VYALEV for adults living with advanced Parkinson’s disease

U.S. FDA approves Pfizer’s HYMPAVZI for adults and adolescents with hemophilia A or B without inhibitors

Manufacturiung

MANUFACTURING

Process filter maker creates new global pharma and healthcare role

A UK process filter manufacturer has appointed a top sales and procurement expert with extensive experience of biotech engineering to lead its strategy for...

GSK to make up to $800m manufacturing investment in Pennsylvania

FibroBiologics and Charles River collaborate to manufacture fibroblast cell-based therapies for chronic diseases

£4.5m project launched to tackle acute skills shortage in UK medicines manufacturing

New $4.5bn Lilly site to drive innovation in drug production and make medicines for clinical trials

Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Finance

AbbVie to acquire Aliada Therapeutics

Lundbeck to acquire Longboard Pharmaceuticals

ProductLife Group acquires life science consulting firm Halloran

Recordati to acquire global rights to Enjaymo

Research & Development
Latest

R&D

GSK to acquire CMG1A46 from Chimagen Biosciences, expanding immunology pipeline

31st October 2024

GSK and Chimagen Biosciences have announced an agreement for GSK to acquire CMG1A46, a clinical-stage dual CD19 and CD20-targeted T cell-engager (TCE), from Chimagen...

R&D

Dyno Therapeutics forms partnership with Roche to advance AAV gene therapy vectors for neurological diseases

30th October 2024

Dyno Therapeutics, a genetic technologies company applying artificial intelligence (AI) to enable in vivo gene delivery, has announced its second research collaboration with Roche...

R&D

ViaNautis Bio signs agreement with Lilly to develop novel products delivering genetic medicines

29th October 2024

ViaNautis Bio, a biotechnology company at the forefront of delivering targeted genetic nanomedicines, has announced a collaboration with Eli Lilly and Company. Under the terms...

R&D

AbbVie and Gedeon Richter to discover and develop novel targets for neuropsychiatric conditions

25th October 2024

AbbVie and Gedeon Richter have announced a new discovery, co-development and license agreement to advance novel targets for the potential treatment of neuropsychiatric conditions. This...

R&D

Cancer Research UK and KisoJi Biotechnology collaborate to advance the first naked antibody against TROP2 into the clinic

24th October 2024

Cancer Research UK, one of the world’s largest funders of cancer research, and KisoJi Biotechnology, a company focussed on the discovery and development of...